CLEVER Pilot Trial: A Phase II Pilot Trial of HydroxyChLoroquine, EVErolimus or the Combination for Prevention of Recurrent Breast Cancer

NCT03032406 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

53

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer Stage IIB

Interventions

DRUG: Hydroxychloroquine
DRUG: Everolimus

Sponsor

Abramson Cancer Center at Penn Medicine